ARTICLE | Clinical News
Romosozumab: Phase III data
September 7, 2015 7:00 AM UTC
Top-line data from the open-label, international Phase III STRUCTURE trial in 436 postmenopausal women with osteoporosis at high risk for fracture who were previously treated with bisphosphonate thera...